Gilead Sciences sets aside $200 million to resolve HIV drug probe
Gilead Sciences set aside $200 million for a potential settlement with federal prosecutors to resolve an investigation into ...
CNN4y
Gilead Sciences, Inc.
Gilead Sciences, Inc. is a biopharmaceutical ... Riordan on June 22, 1987 and is headquartered in Foster City, CA.
Barchart on MSN2d
Gilead Sciences - Leader in HIV Medicines
Your FREE insider update on the biggest news stories and investing trends, delivered midday TheChart of the Day belongs to ...
PipelineReview.com4d
Gilead Presents New HIV Treatment and Cure Research Data at CROI 2025, Including an Investigational Long-Acting, Twice-Yearly Therapy Option
Long-Term Outcomes Reinforce the High Efficacy of Biktarvy ® in People with HIV and HBV Coinfection – – Investigational Long-Acting, Twice-Yearly Treatment Regimen of Len ...
Business Wire1mon
Gilead Sciences Announces 2.6 Percent Increase in First Quarter 2025 Dividend
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared an increase of 2.6% in the company’s quarterly ...
Morningstar27d
Gilead Gets FDA Priority Review of Twice-Yearly Shot to Prevent HIV
Gilead Sciences has won Food and Drug Administration ... the virus that causes AIDS. The Foster City, Calif., biopharmaceutical company has previously said it is planning for a potential launch ...
Nasdaq1mon
Gilead Sciences Announces 2.6 Percent Increase in First Quarter 2025 Dividend
with headquarters in Foster City, Calif. For more information about Gilead, please visit the company’s website at www.gilead.com, follow Gilead on X/Twitter (@Gilead Sciences) and LinkedIn ...